Phio Pharmaceuticals (PHIO) Current Deferred Revenue (2011 - 2014)
Phio Pharmaceuticals' (PHIO) quarterly Current Deferred Revenue came in at $47000.0 in Q4 2014, down 60.17% YoY from $118000.0 in Q4 2013, and down 22.95% on a QoQ basis from $61000.0 in Q3 2014.
Phio Pharmaceuticals (PHIO) Current Deferred Revenue (2011 - 2014) Analysis & Trends
Phio Pharmaceuticals (PHIO) has 4 years of Current Deferred Revenue data on file, last reported at $47000.0 in Q4 2014.
- Quarterly Current Deferred Revenue fell 60.17% year-over-year to $47000.0 in Q4 2014, while the trailing twelve-month figure through Dec 2014 was $47000.0 (down 60.17% YoY) and the FY2014 annual result came in at $47000.0, down 60.17% from the prior year.
- Current Deferred Revenue slipped to $47000.0 in Q4 2014, from $61000.0 in the prior quarter.
- In the past five years, Current Deferred Revenue ranged from a high of $816000.0 in Q4 2011 to a low of $47000.0 in Q4 2014.
- A 4-year average of $321923.1 and a median of $239000.0 in 2013 frame the typical range for Current Deferred Revenue.
- Annual changes were most pronounced in 2012 — Current Deferred Revenue sank 39.83% — and 2014, when it slumped 80.82%.
- Tracing PHIO's Current Deferred Revenue over 4 years: stood at $816000.0 in 2011, then slumped by 39.83% to $491000.0 in 2012, then tumbled by 75.97% to $118000.0 in 2013, then tumbled by 60.17% to $47000.0 in 2014.
- The last three Current Deferred Revenue figures came in at $47000.0 (Q4 2014), $61000.0 (Q3 2014), and $78000.0 (Q2 2014), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn |
| 10 | Phio Pharmaceuticals | 14.06 Mn | 14.06 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2014 | 47,000.00 |
| Sep 30, 2014 | 61,000.00 |
| Jun 30, 2014 | 78,000.00 |
| Mar 31, 2014 | 89,000.00 |
| Dec 31, 2013 | 118,000.00 |
| Sep 30, 2013 | 147,000.00 |
| Jun 30, 2013 | 239,000.00 |
| Mar 31, 2013 | 464,000.00 |
| Dec 31, 2012 | 491,000.00 |
| Sep 30, 2012 | 370,000.00 |
| Jun 30, 2012 | 468,000.00 |
| Mar 31, 2012 | 797,000.00 |
| Dec 31, 2011 | 816,000.00 |